Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -10.013% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a Cc1ccc(C(=O)NCC2CCCO2)cc1S(=O)(=O)N1CCCCC1
b CC(C)COc1cccc(C(=O)NNC(=O)C2COc3ccccc3O2)c1
c Cc1cc(NC(=O)c2ccccc2Cl)n(C(C)(C)C)n1
Answer: a. Cc1ccc(C(=O)NCC2CCCO2)cc1S(=O)(=O)N1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(C(=O)NCC2CCCO2)cc1S(=O)(=O)N1CCCCC1
Cc1ccc(C(=O)NCC2CCCO2)cc1S(=O)(=O)N1CCCCC1
4-methyl-N-(oxolan-2-ylmethyl)-3-piperidin-1-ylsulfonylbenzamide